$61
Availability
In stock
Last checked
3 hours ago
A synthetic dual agonist peptide of the GIP and GLP-1 receptors.
Observed median price
$86
2
Active listings
29 · 99.8%
Independent lab tests
$61–$110
Observed price range
4
Known aliases
Read from the certificate, not re-measured by VialGrade.
Understand this compound
The dual GIP/GLP-1 agonist behind Mounjaro and Zepbound, studied heavily in weight and metabolic research.
Good to know: GI adverse events are the most common trial finding, and the source/purity of non-prescription 'research' tirzepatide is unverified.
A dual GIP/GLP-1 receptor agonist; activates both incretin receptors to enhance glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite.
Mechanism of action from published research — how the molecule behaves, not a claim about any product or any human-use effect.
Studied for type-2 diabetes glycemic control and obesity/weight management, plus obstructive sleep apnea and other metabolic conditions.
FDA-approved (for type-2 diabetes and obesity); approved as Mounjaro (2022) and Zepbound (2023), including a 2024 sleep apnea indication.
Where the science stands — an approved drug is not the same as the research-grade material a vendor sells, which is unregulated regardless.
Research context only — VialGrade never gives dosing, medical, or human-use guidance.
This is a prescription drug in the US
This is the active drug in Mounjaro and Zepbound — an FDA-approved prescription medication. Buying a “research” version sidesteps the prescription requirement and the approved, quality-controlled supply chain. The FDA has warned about and acted against unapproved and compounded copies. Higher legal and safety exposure than an unapproved research peptide.
Read the full US legal overview →General information, not legal or medical advice. VialGrade sells nothing and encourages no human use.
Reference source
Tirzepatide is the active ingredient in FDA-approved medicines made by Eli Lilly (Mounjaro, Zepbound). Grey-market “Tirzepatide” sold for research is not Eli Lilly’s product and is not the FDA-approved drug — a different, unregulated supply chain under the same chemical name. See what pharmaceutical-grade means →
Current market
$61
Availability
In stock
Last checked
3 hours ago
$110
$22.0/mg
Availability
In stock
Last checked
1 hour ago
Independent testing
Real, publicly verifiable third-party tests. Purity is read from the certificate itself. A test reflects one lab’s result for one submitted batch — not a guarantee that every vial matches.
Every record below is a real certificate of analysis, gathered two ways: from the public verification feeds that independent labs (like Janoshik) publish, and from the certificates vendors post on their own product pages. We open each certificate document and read the measured purity, content, batch, and date directly off it — a scraper can’t read a number printed inside an image, so this is done by machine vision, then recorded here with a link back to the original.
Nothing here is typed in by a vendor or invented by us. Where a certificate is missing, we say so rather than filling the gap.
We re-check the lab feed, too. A “still listed” tag means the certificate is currently public in Janoshik’s database — we re-verify against the live feed and stamp the date. If a cert is later pulled, the tag flips. It’s a freshness check on the same source, not a second independent opinion.
Three different questions. Purity (“how clean?”), identity (“is it the right molecule?”, a mass-spec test), and content (“did I get the labeled mg?”) are separate. A vial can be 99% pure and still be the wrong peptide, or the right peptide underdosed. We flag the measured dose against the label above; underdosing is the most common real fraud.
Who submitted the sample matters. Most of these are vendor-submitted — the seller chose which vial to send, so one good certificate doesn’t prove every batch is the same. The gold standard is a blind test, where a buyer sends a vial they bought as a normal customer. Same label doesn’t prove same product; same batch number doesn’t prove same batch.
15
blind tests
100.0%
highest tested purity
| Certificate | Manufacturer | Batch | Purity | Content / dose | Lab | |
|---|---|---|---|---|---|---|
| www.optimumsourceresearch.com Blind | T-031026-01 | 99.89% | 24.54/20mg · | Janoshik Analytical Still listed | Verify | |
| www.ssrbio.com Blind | 2026 | 99.89% | 33.67/30mg · full | Janoshik Analytical Still listed | Verify | |
| https://www.rayshine-peptide.com/ Blind | RSP20260315 | 99.85% | 32.74/30mg · full | Janoshik Analytical Still listed | Verify | |
| liliPetide Technology Co., Ltd. Blind | — | 99.84% | 35.58/30mg · full | Janoshik Analytical Still listed | Verify | |
| http://www.sahepeptides.com/ Blind | — | 99.81% | 34.73/30mg · full | Janoshik Analytical Still listed | Verify | |
| https://www.htraresearch.cn Blind | — | 99.75% | 21.79/20mg · full | Janoshik Analytical Still listed | Verify | |
| www.uwa-biotech.com Blind | blue | 99.69% | 45.42/40mg · full | Janoshik Analytical Still listed | Verify | |
| Whatsapp:①+852-56419109 ②+44 7467 123605 Blind | June 12, 2026 | 99.69% | 31.96/30mg · full | Janoshik Analytical Still listed | Verify | |
| Kangpeptide Technology Co., Ltd Blind | — | 99.69% | 17.37/15mg · full | Janoshik Analytical Still listed | Verify | |
| www.jianxilab.com Blind | — | 99.67% | 10.31/10mg · full | Janoshik Analytical Still listed | Verify | |
| peptidesfactorycn.com Blind | 4 | 99.64% | 22.81/20mg · full | Janoshik Analytical Still listed | Verify | |
| www.certapeptides.com Blind | CP-2605-TR10 | 99.60% | 11.24/10mg · full | Janoshik Analytical Still listed | Verify | |
| https://www.hhmpeptide.com/ Blind | — | 99.51% | 22.53/20mg · full | Janoshik Analytical Still listed | Verify | |
| www.certapeptides.com Blind | CP-2604-TIR5 | 99.50% | 5.48/5mg · full | Janoshik Analytical Still listed | Verify | |
| hangzhoupeps.com Blind | — | 99.03% | 11.14/10mg · full | Janoshik Analytical Still listed | Verify | |
| https://zztai-tech.com/ | — | 99.97% | 31.4/30mg · full | Janoshik Analytical Still listed | Verify | |
| www.innopeptide.com | T60/2025-12-18-B | 99.95% | 60.24/60mg · full | Janoshik Analytical Still listed | Verify | |
| http://www.zlzpeptide.com/ | — | 99.93% | 134.16/120mg · full | Janoshik Analytical Still listed | Verify | |
| Aura | — | 99.90% | 67.18/60mg · full | Janoshik Analytical Still listed | Verify | |
| Peptide Pros | 2023-08-08 | 99.90% | — | MZ Biolabs | Verify |
Tested batches
The full test history for one batch — who picked the sample, who tested it, and what came back. It describes the vials that were tested, never every vial they sold.
Research summaries describe published literature and market data only. They do not establish the identity, quality, safety, or legal status of any listed physical product.